Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesse Roman

Showing results (21-30 of 214) with videos related to

Pageof 22
Sort By:
Expert Review of Respiratory Medicine|May 19, 2010
Treating refractory asthma with antibodies against IL-5: is it ready for prime time?Faisal Ahmad, Jesse Roman
Anti-Cancer Drugs|February 1, 2007
Peroxisome proliferator-activated receptor gamma: a novel target for cancer therapeutics?ShouWei Han, Jesse Roman
Lung Cancer (Amsterdam, Netherlands)|December 27, 2005
COX-2 inhibitors suppress lung cancer cell growth by inducing p21 via COX-2 independent signalsShouWei Han, Jesse Roman
Experimental Lung Research|October 14, 2008
Apoptosis of mesenchymal cells during the pseudoglandular stage of lung development affects branching morphogenesisCherry Wongtrakool, Jesse Roman
International Journal of Cancer|April 13, 2005
COX-2 inhibitors suppress integrin alpha5 expression in human lung carcinoma cells through activation of Erk: involvement of Sp1 and AP-1 sitesShouWei Han, Jesse Roman
American Journal of Respiratory Cell and Molecular Biology|March 16, 2021
B Cells in Idiopathic Pulmonary Fibrosis: Targeting Immune Cells with Antifibrotic AgentsJesse Roman, Hirofumi Chiba
The American Journal of the Medical Sciences|July 8, 2020
Endemic and Emerging Coronavirus Pulmonary InfectionsMatthew Flamenbaum, Jesse Roman
Biochemical and Biophysical Research Communications|January 31, 2004
Suppression of prostaglandin E2 receptor subtype EP2 by PPARgamma ligands inhibits human lung carcinoma cell growthShouWei Han, Jesse Roman
The Journal of Pathology|October 16, 2015
Studying human respiratory disease in animals--role of induced and naturally occurring modelsKurt Williams, Jesse Roman
Molecular Cancer Therapeutics|March 1, 2006
Rosiglitazone suppresses human lung carcinoma cell growth through PPARgamma-dependent and PPARgamma-independent signal pathwaysShouWei Han, Jesse Roman
Pageof 22

Showing results (21-30 of 214) with videos related to

Sort By:
Pageof 22
Expert Review of Respiratory Medicine|May 19, 2010
Treating refractory asthma with antibodies against IL-5: is it ready for prime time?Faisal Ahmad, Jesse Roman
Anti-Cancer Drugs|February 1, 2007
Peroxisome proliferator-activated receptor gamma: a novel target for cancer therapeutics?ShouWei Han, Jesse Roman
Lung Cancer (Amsterdam, Netherlands)|December 27, 2005
COX-2 inhibitors suppress lung cancer cell growth by inducing p21 via COX-2 independent signalsShouWei Han, Jesse Roman
Experimental Lung Research|October 14, 2008
Apoptosis of mesenchymal cells during the pseudoglandular stage of lung development affects branching morphogenesisCherry Wongtrakool, Jesse Roman
International Journal of Cancer|April 13, 2005
COX-2 inhibitors suppress integrin alpha5 expression in human lung carcinoma cells through activation of Erk: involvement of Sp1 and AP-1 sitesShouWei Han, Jesse Roman
American Journal of Respiratory Cell and Molecular Biology|March 16, 2021
B Cells in Idiopathic Pulmonary Fibrosis: Targeting Immune Cells with Antifibrotic AgentsJesse Roman, Hirofumi Chiba
The American Journal of the Medical Sciences|July 8, 2020
Endemic and Emerging Coronavirus Pulmonary InfectionsMatthew Flamenbaum, Jesse Roman
Biochemical and Biophysical Research Communications|January 31, 2004
Suppression of prostaglandin E2 receptor subtype EP2 by PPARgamma ligands inhibits human lung carcinoma cell growthShouWei Han, Jesse Roman
The Journal of Pathology|October 16, 2015
Studying human respiratory disease in animals--role of induced and naturally occurring modelsKurt Williams, Jesse Roman
Molecular Cancer Therapeutics|March 1, 2006
Rosiglitazone suppresses human lung carcinoma cell growth through PPARgamma-dependent and PPARgamma-independent signal pathwaysShouWei Han, Jesse Roman
Pageof 22